Ferric Carboxymaltose Solution for Injection 500mg (Ferinject® / フェインジェクト静注500mg)

JPY ¥8,600

Japanese Iron Deficiency Anemia Treatment Agent (Ferric Carboxymaltose 500mg). For slow intravenous injection or infusion; once weekly administration. 10mL x 1 vial. Mfd. by Zeria Pharmaceutical Co., Ltd., Japan.

Bulk deal
Quantity Discount Discounted price
5 - 9 8% JPY ¥7,912
10 - 19 12% JPY ¥7,568
20 + 18% JPY ¥7,052
SKU: FRJ-500-INJ Category:

Description

Product Overview / 商品概要

Ferinject Solution for Injection/Infusion 500mg (フェインジェクト静注500mg)
Generic: Ferric Carboxymaltose / カルボキシマルトース第二鉄
Therapeutic Category: Iron Deficiency Anemia Treatment Agent / 鉄欠乏性貧血治療剤
Manufactured by: Zeria Pharmaceutical Co., Ltd. / ゼリア新薬工業株式会社

Composition & Specification / 組成・規格

Active Ingredient: Ferric Carboxymaltose equivalent to 500mg of iron per 1 vial (10mL) / 1バイアル(10mL)中にカルボキシマルトース第二鉄を鉄として500mg含有する
Additives: pH adjuster / pH調整剤
Appearance: Dark brown opaque solution; pH 5.0–7.0; osmolarity ratio 1.0–1.3 (relative to normal saline)
外観: 暗褐色の不透明な液、pH 5.0~7.0、浸透圧比 1.0~1.3(生理食塩液に対する比)

Indications / 効能効果

EN: Iron deficiency anemia
JA: 鉄欠乏性貧血

Dosage and Administration / 用法用量

EN: Usually, administer 500mg of iron per dose once weekly by slow intravenous injection or infusion in adults. The total dose depends on the patient’s hemoglobin level and body weight, with a maximum total dose of 1,500mg of iron.
JA: 通常、成人に鉄として1回あたり500mgを週1回、緩徐に静注又は点滴静注する。総投与量は、患者の血中ヘモグロビン値及び体重に応じるが、上限は鉄として1,500mgとする。

Contraindications / 禁忌

EN: Patients without iron deficiency (risk of iron overload); patients with a history of hypersensitivity to this product
JA: 鉄欠乏状態にない患者(鉄過剰を来すおそれがある)、本剤に対し過敏症の既往歴のある患者

Regulatory Information / 規制情報

Approval No.: 23100AMX00290000
Sales Started: September 2020 / 2020年9月
Classification Code: 873222
Storage: Store at room temperature; avoid freezing / 室温保存(凍結を避けて保存)
Shelf Life: 3 years / 3年

Packaging / 包装

Main Package (for sale): 10mL x 1 vial / 10mL×1バイアル
Other Available Packages (by special order): 10mL x 1 vial, 10mL x 5 vials

Full product insert (添付文書) is attached as a downloadable PDF. For detailed precautions, drug interactions, and safety information, please refer to the official package insert.

Additional information

重さ 0.15 kg

Reviews

There are no reviews yet.

Be the first to review “Ferric Carboxymaltose Solution for Injection 500mg (Ferinject® / フェインジェクト静注500mg)”

メールアドレスが公開されることはありません。 ※ が付いている欄は必須項目です

Export from Japan — Ferric Carboxymaltose Solution for Injection 500mg (Ferinject®

🏭 Supply & Origin

  • Country of Origin: Japan
  • Regulatory Standard: PMDA (Japan) / GMP Compliant
  • Pharmacopoeia: Japanese Pharmacopoeia (JP)
  • Supplier: Mate Co., Ltd. — Licensed Pharmaceutical Wholesaler (License No. B14309, Osaka)
  • Supply Capacity: Full-line sourcing through Japan's regulated distribution channels

🚚 Shipping & Trade Terms

  • Incoterms: FOB Kansai International Airport (KIX)
  • Shipping: Air freight via B/L or AWB
  • Payment: 100% T/T in advance
  • Lead Time: 2-4 weeks after payment confirmation
  • Available Regions: EU, LATAM, APAC, Middle East, Africa

Request a Quotation

For pricing, MOQ, and regulatory documentation, contact our export team:

Email: kurimoto@mate-osaka.co.jp
Tel: +81-72-665-5736

All exports are conducted through proper regulatory procedures including customs clearance, B/L or AWB documentation, and T/T advance payment. We do not engage in hand-carry, cash transactions, or sales to unlicensed parties.